Learn how and where to inject Zepbound and where to get additional help. Plus, get tips for injecting the drug at home and ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep medicine.

Viking's Q1 earnings show no revenue, increased R&D spending, and a substantial cash reserve, positioning it well for future ...

The India launch of Eli Lilly's popular weight-loss drug Mounjaro has triggered a huge wave of patient enquiries about its ...

The trial included 751 patients from the United States and Puerto Rico who were randomized to receive the maximum tolerated dose of Wegovy (10 or 15 mg) or Zepbound (1.7 or 2.4 mg). The ...

Its highest dose is 15mg. A patient in India may have to spend ... although the amount patients pay largely depends on their insurance plan. Zepbound, which has the same active ingredient ...

Long-term use of tirzepatide shows sustained and significant weight loss in adults with overweight or obesity.

Zepbound earned $4.93bn in 2024 ... with doses ranging from 2.5mg to 15mg. Lilly says in a statement: Every major medical organization and establishment recognizes obesity as a chronic disease ...

Adults with overweight or obesity plus prediabetes maintain most of their weight loss with tirzepatide at more than 3 years, ...

Mounjaro's launch of a weight-loss drug has sparked interest amongst the people of India despite the high price. Experts believe that making the drug locally available would help to reduce the black ...

For adults struggling with weight, a weekly injection of tirzepatide offers real hope. Recent findings presented at the European Congress on Obesity (ECO) in Malaga, Spain, reveal that the drug leads ...